PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 3	2025-03-13		NCT04557501

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
British Columbia Cancer Agency	58
Canadian Cancer Society (CCS)	26
Centre hospitalier de l'Université de Montréal (CHUM)	138
Institute of Health Economics, Canada	3
Lantheus Medical Imaging	15
London Health Sciences Centre	37
McMaster University	202
Princess Margaret Hospital, Canada	28
Queen's University	45
Tom Baker Cancer Centre	7

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BC Cancer Kelowna	Kelowna	Canada	1
BC Cancer Vancouver	Vancouver	Canada	1
Cancer Care Manitoba	Winnipeg	Canada	2
Charles Lemoyne Hospital	Montreal	Canada	1
CHU de Québec	Québec	Canada	3
CHUM	Montreal	Canada	3
CHUS	Sherbrooke	Canada	1
Cross Cancer Institute	Edmonton	Canada	4
Grand River Regional Cancer Centre	Kitchener	Canada	4
Hopital de la Cité de la Santé	Laval	Canada	1
Jewish General Hospital	Montreal	Canada	7
Juravinski Cancer Centre	Hamilton	Canada	24
London Health Sciences Centre	London	Canada	58
McGill University Health Center	Montreal	Canada	27
Princess Margaret Cancer Centre	Toronto	Canada	9
Royal Victoria Regional Health Centre	Barrie	Canada	35
St-Joseph's Healthcare	Hamilton	Canada	1
Tom Baker Cancer Center	Calgary	Canada	2
Windsor Regional Cancer Centre	Windsor	Canada	1